ARTA
ANIK icon

A.R.T. Advisors’s Anika Therapeutics ANIK Stock Holding History

A.R.T. Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,706
Closed -$711K – 99
2019
Q4 		$711K Buy
13,706
+7,200
+111% +$418K 0.04% 687
2019
Q3 		$357K Sell
6,506
-8,400
-56% -$431K 0.02% 991
2019
Q2 		$605K Buy
+14,906
New +$544K 0.03% 670
2018
Q4 		– Sell
-28,212
Closed -$1.19M – 1296
2018
Q3 		$1.19M Buy
28,212
+17,750
+170% +$701K 0.05% 500
2018
Q2 		$334K Sell
10,462
-6,441
-38% -$265K 0.01% 1072
2018
Q1 		$840K Buy
16,903
+6,600
+64% +$373K 0.03% 728
2017
Q4 		$555K Buy
10,303
+4,600
+81% +$255K 0.02% 853
2017
Q3 		$330K Buy
+5,703
New +$298K 0.02% 974
2017
Q2 		– Sell
-12,900
Closed -$560K – 1381
2017
Q1 		$560K Buy
12,900
+3,500
+37% +$167K 0.03% 774
2016
Q4 		$460K Buy
+9,400
New +$435K 0.03% 783
2016
Q2 		– Sell
-22,858
Closed -$1.02M – 1342
2016
Q1 		$1.02M Buy
22,858
+1,100
+5% +$44.6K 0.05% 578
2015
Q4 		$830K Buy
21,758
+13,400
+160% +$513K 0.04% 655
2015
Q3 		$266K Sell
8,358
-9,907
-54% -$345K 0.01% 1078
2015
Q2 		$603K Buy
18,265
+12,752
+231% +$455K 0.02% 924
2015
Q1 		$226K Sell
5,513
-34,493
-86% -$1.39M 0.01% 1196
2014
Q4 		$1.63M Buy
40,006
+4,502
+13% +$176K 0.06% 451
2014
Q3 		$1.3M Buy
35,504
+12,646
+55% +$546K 0.06% 430
2014
Q2 		$1.06M Buy
22,858
+12,257
+116% +$545K 0.06% 484
2014
Q1 		$435K Buy
+10,601
New +$394K 0.02% 814

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

A.R.T. Advisors's ANIK Position: Q1 2020 in Review

A.R.T. Advisors sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 13,706 shares — an estimated $711K sold.

A.R.T. Advisors first reported a position in ANIK in Q1 2014 and held it in 19 quarters. The position peaked at $1.63M in Q4 2014. 163 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • A.R.T. Advisors reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 13,706 Anika Therapeutics shares in Q1 2020, an estimated $711K.
  • A.R.T. Advisors first reported a position in Anika Therapeutics in Q1 2014 and held it in 19 quarters.
  • A.R.T. Advisors's Anika Therapeutics position peaked at $1.63M in Q4 2014.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.